Takeda Pharmaceutical Co., Ltd. (TAK)
18.29
+0.05
(+0.27%)
USD |
NYSE |
Aug 25, 12:57
Takeda Pharmaceutical Total Liabilities (Quarterly) : 49.87B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 49.87B |
| March 31, 2026 | 50.79B |
| December 31, 2025 | 49.54B |
| September 30, 2025 | 49.69B |
| June 30, 2025 | 49.42B |
| March 31, 2025 | 48.90B |
| December 31, 2024 | 48.92B |
| September 30, 2024 | 53.49B |
| June 30, 2024 | 52.40B |
| March 31, 2024 | 51.77B |
| December 31, 2023 | 53.06B |
| September 30, 2023 | 52.28B |
| June 30, 2023 | 54.46B |
| March 31, 2023 | 57.13B |
| December 31, 2022 | 55.54B |
| September 30, 2022 | 54.41B |
| June 30, 2022 | 57.03B |
| March 31, 2022 | 61.75B |
| December 31, 2021 | 63.97B |
| September 30, 2021 | 64.85B |
| June 30, 2021 | 66.84B |
| March 31, 2021 | 70.00B |
| December 31, 2020 | 74.06B |
| September 30, 2020 | 73.42B |
| June 30, 2020 | 73.44B |
| Date | Value |
|---|---|
| March 31, 2020 | 74.97B |
| December 31, 2019 | 75.04B |
| September 30, 2019 | 74.12B |
| June 30, 2019 | 80.53B |
| March 31, 2019 | 77.76B |
| December 31, 2018 | 33.95B |
| September 30, 2018 | 18.51B |
| June 30, 2018 | 18.90B |
| March 31, 2018 | 19.64B |
| December 31, 2017 | 20.21B |
| September 30, 2017 | 20.17B |
| June 30, 2017 | 20.55B |
| March 31, 2017 | 21.60B |
| December 31, 2016 | 17.98B |
| September 30, 2016 | 18.99B |
| June 30, 2016 | 18.99B |
| March 31, 2016 | 16.13B |
| December 31, 2015 | 16.85B |
| September 30, 2015 | 16.96B |
| June 30, 2015 | 17.07B |
| March 31, 2015 | 17.43B |
| December 31, 2014 | 17.35B |
| September 30, 2014 | 18.60B |
| June 30, 2014 | 19.58B |
| March 31, 2014 | 19.29B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Daiichi Sankyo Co., Ltd. | 14.84B |
| Ono Pharmaceutical Co., Ltd. | 1.302B |
| Astellas Pharma, Inc. | 10.76B |
| Sanofi | -- |
| Eisai Co., Ltd. | 3.845B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.37B |
| Shareholders Equity (Quarterly) | 46.50B |
| Debt to Equity Ratio | 0.6536 |
| Current Ratio | 1.140 |
| Net Debt Paydown Yield | 1.43% |